Format

Send to

Choose Destination
PLoS One. 2016 May 2;11(5):e0154846. doi: 10.1371/journal.pone.0154846. eCollection 2016.

Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?

Author information

1
Nuclear Medicine Division, Second Affiliated Hospital, Dalian Medical University, Dalian 116023, China.
2
Department of Cell Biology and the Liaoning Provincial Key Laboratory of Cancer Genomics and Epigenetics, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.

Abstract

OBJECTIVES:

Although it is well accepted that there is a close relationship between hypothyroidism and depression, previous studies provided inconsistent or even opposite results in whether subclinical hypothyroidism (SCH) increased the risk of depression. One possible reason is that the etiology of SCH in these studies was not clearly distinguished. We therefore investigated the relationship between SCH resulting from 131I treatment of Graves' disease and depression.

DESIGN AND METHODS:

The incidence of depression among 95 patients with SCH and 121 euthyroid patients following 131I treatment of Graves' disease was studied. The risk factors of depression were determined with multivariate logistic regression analysis. Thyroid hormone replacement therapy was performed in patients with thyroid-stimulating hormone (TSH) levels exceeding 10 mIU/L.

RESULTS:

Patients with SCH had significantly higher Hamilton Depression Scale scores, serum TSH and thyroid peroxidase antibody (TPOAb) levels compared with euthyroid patients. Multivariate logistic regression analysis revealed SCH, Graves' eye syndrome and high serum TPO antibody level as risk factors for depression. L-thyroxine treatment is beneficial for SCH patients with serum TSH levels exceeding 10 mIU/L.

CONCLUSIONS:

The results of the present study demonstrated that SCH is prevalent among 131I treated Graves' patients. SCH might increase the risk of developing depression. L-thyroxine replacement therapy helps to resolve depressive disorders in SCH patients with TSH > 10mIU/L. These data provide insight into the relationship between SCH and depression.

PMID:
27135245
PMCID:
PMC4852890
DOI:
10.1371/journal.pone.0154846
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center